Acrizanib (LHA510)
CAS: 1229453-99-9
Ref. 3D-EZB45399
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Acrizanib is a tyrosine kinase inhibitor that has been shown to reduce the growth of new blood vessels in the eye. Acrizanib inhibits the production of angiogenic growth factors by inhibiting the activity of the VEGF receptor and blocking the binding of VEGF to its receptor. Acrizanib has also been shown to inhibit the activity of other tyrosine kinases, including fibroblast growth factor receptors 1 and 2 (FGFR1 and FGFR2). Acrizanib is administered as an intravitreal injection, which reduces or prevents neovascularization in ocular tissues.
Chemical properties
Technical inquiry about: 3D-EZB45399 Acrizanib (LHA510)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
